The global market for genital herpes treatment is poised for remarkable growth, with estimates indicating that it will surpass USD 2.14 billion by the end of 2023. This upward trajectory is expected to continue, as the market is forecasted to achieve a significant compound annual growth rate (CAGR) of 5.2% through 2033, ultimately reaching an estimated value of USD 3.55 billion.The increasing …